These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4778727)
21. The Committee on Safety of Medicines. Goldberg A Health Bull (Edinb); 1981 Nov; 39(6):393-7. PubMed ID: 7035402 [No Abstract] [Full Text] [Related]
22. Crying wolf on drug safety. Br Med J (Clin Res Ed); 1982 Jan; 284(6311):219-20. PubMed ID: 6799107 [No Abstract] [Full Text] [Related]
23. Remarks at the Food and Drug Law Institute's 48th Annual Conference. Niedelman SM Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089 [No Abstract] [Full Text] [Related]
24. The European Medicines Evaluation Agency. Bosanquet N BMJ; 1994 Feb; 308(6926):430. PubMed ID: 8124171 [No Abstract] [Full Text] [Related]
26. The convention on psychotropic substances: why it should be ratified. Rosen JA J Leg Med (N Y); 1974; 2(3):44-7. PubMed ID: 4546226 [No Abstract] [Full Text] [Related]
27. AN INTERNATIONAL DRUG SAFEGUARD PLAN. FINNEY DJ J Chronic Dis; 1964 Jul; 17():565-81. PubMed ID: 14179659 [No Abstract] [Full Text] [Related]
28. Present attitudes of governmental drug regulatory agencies. Noel PR Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283 [No Abstract] [Full Text] [Related]
29. Medicine and public affairs: Kennedy urges further pharmaceutical regulation. Greenberg DS N Engl J Med; 1974 May; 290(21):1211-2. PubMed ID: 4824024 [No Abstract] [Full Text] [Related]
30. The international (mainly European) attitude to the drug driving problem--legislation and countermeasures. Irving A Int Clin Psychopharmacol; 1988 May; 3 Suppl 1():13-21. PubMed ID: 3403945 [No Abstract] [Full Text] [Related]
31. [Is drug therapy safer as a result of the drug legislation?]. Kimbel KH Internist (Berl); 1980 Jun; 21(6):306-10. PubMed ID: 7005166 [No Abstract] [Full Text] [Related]
32. Changes to drug names. Loe B Nurs N Z; 2008 Mar; 14(3):3-4. PubMed ID: 18494130 [No Abstract] [Full Text] [Related]
33. Regulatory milieu in India. Sheth UK Clin Pharmacol Ther; 1976 May; 19(5 Pt 2):704-9. PubMed ID: 1269212 [No Abstract] [Full Text] [Related]
34. The inadequate treatment of pain: collateral damage from the war on drugs. Nickerson JW; Attaran A PLoS Med; 2012 Jan; 9(1):e1001153. PubMed ID: 22253576 [TBL] [Abstract][Full Text] [Related]
35. Regulatory toxicology: objectives and tasks defined by the working group of the German society of experimental and clinical pharmacology and toxicology. Mayer D Toxicol Lett; 2002 Feb; 126(3):161-2. PubMed ID: 11814702 [No Abstract] [Full Text] [Related]
36. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
37. Drugs: their uses and abuses, and the problem of their control. Dunlop D Vet Rec; 1969 Oct; 85(16):424-9. PubMed ID: 5387898 [No Abstract] [Full Text] [Related]
38. WHO to set up international task force on counterfeit drugs. Zarocostas J BMJ; 2006 Feb; 332(7539):444. PubMed ID: 16497756 [No Abstract] [Full Text] [Related]
39. Compensation for drug injury: two solutions to an insoluble problem. Smith R Br Med J (Clin Res Ed); 1981 May; 282(6276):1610-2. PubMed ID: 6786584 [No Abstract] [Full Text] [Related]
40. [The control of medicines and related substances, Law 101 of 1965: a short review]. Bam WJ S Afr Med J; 1977 Jan; 51(1):9-12. PubMed ID: 835036 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]